Stocktoria
BIO-TECHNE Corp TECH
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1989-02-09
BIO-TECHNE Corp insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Crouse Steven C. | President - Diag & Spatial Bi | 2026-06-02 | Tax withheld | 216 | $49.77 |
| Crouse Steven C. | President - Diag & Spatial Bi | 2026-06-02 | Option exercise | 600 | — |
| Herr Amy E. | director | 2026-05-08 | Option exercise | 6,636 | $47.60 |
| Herr Amy E. | director | 2026-05-08 | Sell | 6,636 | $48.28 |
| Hippel James | CFO | 2026-05-05 | Tax withheld | 56,955 | $56.68 |
| Bohnen Shane | SVP - General Counsel | 2026-05-05 | Option exercise | 8,400 | $47.60 |
| Bohnen Shane | SVP - General Counsel | 2026-05-05 | Tax withheld | 7,055 | $56.68 |
| Hippel James | CFO | 2026-05-05 | Option exercise | 62,000 | $47.60 |
Source: SEC EDGAR filings · CIK 0000842023 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.